PU Conference Series - ASH 2017

ISSN 2208-150X (Print) ISSN 2208-1518 (Online)

59TH AMERICAN SOCIETY OF HEMATOLOGY (ASH) ANNUAL MEETING & EXPOSITION 9–12 DECEMBER 2017 • ATLANTA, GEORGIA, USA

THE BEST OF ASH 2017 CONFERENCE Weekly Subcutaneous Emicizumab a New Standard of Care in Hemophilia Management • bb2121 Anti-BCMA CAR T-Cell Therapy Leads to Durable Clinical Responses in Heavily Pretreated Relapsed/Refractory Multiple Myeloma • CTL019 Produces High 6-Month Response Rates in Highly Pretreated Adult Relapsed/Refractory Diffuse Large B-Cell Lymphoma • BLU-285, a KIT D816V Inhibitor, Proves Promising in Advanced Systemic Mastocytosis • The HbS Polymerization Inhibitor Voxelotor GBT440 Has Demonstrated Positive Initial Results in Adolescents With Sickle Cell Disease

The production and distribution of this publication is sponsored by Gilead Sciences, Australia & New Zealand

Made with FlippingBook HTML5